Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of ergothioneine tablet in China. Welcome to wholesale bulk high quality ergothioneine tablet for sale here from our factory. Good service and reasonable price are available.
Ergothioneine has emerged as a potent compound with a wide array of biological activities. As a naturally occurring antioxidant, it has captured the attention of researchers and health enthusiasts alike. Ergothioneine tablets, as a convenient form of delivering this valuable nutrient, are gaining popularity. This article delves into the scientific foundations, health benefits, and practical applications of ergothioneine tablets, providing a comprehensive understanding of their significance in modern health and wellness.
What is the role of ERGO in the body
Below is a detailed breakdown of ERGO's roles in the body:
Potent Antioxidant Activity
Neutralizes Reactive Oxygen Species (ROS): ERGO scavenges free radicals like hydroxyl radicals (·OH), peroxynitrite (ONOO⁻), and singlet oxygen (¹O₂), which are implicated in cellular damage, aging, and chronic diseases.
Stability Under Oxidative Conditions: Unlike vitamin C or glutathione, ERGO remains stable in biological systems, enabling prolonged antioxidant protection.
Metal Chelation: ERGO binds to transition metals (e.g., iron, copper) that catalyze ROS production, reducing oxidative stress indirectly.
Anti-Inflammatory Effects
Inhibits Pro-Inflammatory Cytokines: ERGO suppresses the production of inflammatory markers like TNF-α, IL-6, and NF-κB, which are elevated in conditions such as arthritis, cardiovascular disease, and neurodegenerative disorders.
Modulates Immune Response: By reducing oxidative stress in immune cells (e.g., macrophages, T-cells), ERGO helps maintain immune homeostasis and prevents chronic inflammation.
Neuroprotective Properties
Crosses the Blood-Brain Barrier (BBB): ERGO's accumulation in the brain protects neurons from oxidative damage, a key factor in neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's.
Supports Mitochondrial Function: ERGO preserves mitochondrial integrity in neurons, enhancing energy production and reducing apoptosis (cell death).
Promotes Autophagy: ERGO may stimulate autophagy, a cellular cleanup process that removes misfolded proteins and damaged organelles, which are hallmarks of neurodegeneration.
Products Information
Ergothioneine +. COA
Case Study
Cognitive Enhancement in Aging Populations
Background
Dementia affects over 55 million people globally, with Alzheimer's disease (AD) contributing to 60–70% of cases. Oxidative stress and neuroinflammation are key drivers of neuronal death in AD, yet no disease-modifying therapies exist. ERGO's neuroprotective properties-demonstrated in rodent models-prompted a 2024 human trial investigating its cognitive effects.
Methodology
A double-blind, placebo-controlled study enrolled 120 adults aged 50–75 with mild cognitive impairment (MCI). Participants received 200 mg ERGO tablets (99.9% purity, bioavailable via liposomal encapsulation) or placebo daily for 12 months. Cognitive function was assessed using the Cognitrax battery, which evaluates memory, attention, and executive function. Serum extracellular vesicles (EVs) were analyzed for phosphorylated TrkB (p-TrkB), a biomarker of neurotrophic signaling.
Results
Cognitive Scores: The ERGO group showed a 22% improvement in composite Cognitrax scores versus 5% in the placebo group (p < 0.01). Domain-specific gains included:
Memory: 18% increase in delayed recall (p = 0.003)
Attention: 15% faster processing speed (p = 0.007)
Biomarker Analysis: Serum EV-derived p-TrkB levels correlated strongly with ERGO concentrations (r = 0.76, p < 0.001) and cognitive scores (r = 0.68, p < 0.001).
Safety: No serious adverse events were reported. Mild gastrointestinal discomfort occurred in 8% of participants, resolving within two weeks.
Mechanistic Insights
ERGO's cognitive benefits are mediated by two pathways:
TrkB Activation: By increasing p-TrkB in hippocampal neurons, ERGO enhances brain-derived neurotrophic factor (BDNF) signaling, promoting synaptic plasticity and neurogenesis.
Mitochondrial Protection: ERGO scavenges mitochondrial superoxide radicals, reducing DNA damage and apoptosis in neurons.
Neuroprotection in Parkinson's Disease
1) Background
Parkinson's disease (PD) is characterized by dopaminergic neuron loss in the substantia nigra, linked to mitochondrial dysfunction and α-synuclein aggregation. ERGO's ability to cross the blood-brain barrier and mitigate oxidative stress makes it a candidate for PD prevention.
2) Methodology
A 2023 preclinical study evaluated ERGO's effects in a 6-OHDA-induced PD rat model. Rats received 50 mg/kg ERGO (oral gavage) or saline daily for 28 days post-lesion. Motor function was assessed using the rotarod test, while brain tissue was analyzed for dopamine levels and α-synuclein deposition.
3) Results
Motor Function: ERGO-treated rats maintained 75% of baseline rotarod performance versus 40% in controls (p < 0.01).
Biochemical Analysis:
Dopamine: Striatal dopamine levels were 40% higher in ERGO-treated rats (p = 0.002).
α-Synuclein: ERGO reduced insoluble α-synuclein aggregates by 55% (p = 0.001).
4) Mechanistic Insights
ERGO's neuroprotective effects in PD stem from:
Mitochondrial Bioenergetics: ERGO enhances complex I activity, restoring ATP production in dopaminergic neurons.
Protein Aggregation Inhibition: By reducing oxidative stress, ERGO prevents α-synuclein misfolding and aggregation.
Metabolic Regulation in Type 2 Diabetes
1) Background
Oxidative stress contributes to insulin resistance and β-cell dysfunction in type 2 diabetes (T2D). ERGO's role in modulating redox balance and inflammation suggests potential benefits for glycemic control.
2) Methodology
A 2025 open-label pilot study enrolled 30 adults with poorly controlled T2D (HbA1c > 7.5%). Participants received 100 mg ERGO tablets twice daily for 12 weeks. Primary outcomes included HbA1c, fasting glucose, and insulin sensitivity (HOMA-IR).
3) Results
Glycemic Control: HbA1c decreased from 8.2% to 7.1% (p < 0.001), while fasting glucose fell by 18% (p = 0.002).
Insulin Sensitivity: HOMA-IR improved by 30% (p = 0.004), correlating with a 25% reduction in serum malondialdehyde (MDA), a marker of oxidative stress.
4) Mechanistic Insights
ERGO improves metabolic health through:
Nrf2 Activation: ERGO induces the transcription factor Nrf2, upregulating antioxidant enzymes like glutathione peroxidase and superoxide dismutase.
Adipokine Modulation: ERGO reduces pro-inflammatory cytokines (e.g., TNF-α) while increasing adiponectin, enhancing insulin signaling.
Skin Health and Photoaging
1) Background
Ultraviolet (UV) radiation generates reactive oxygen species (ROS), leading to collagen degradation and wrinkle formation. ERGO's topical and oral formulations have shown promise in mitigating photoaging.
2) Methodology
A 2024 split-face study enrolled 40 women aged 35–55 with moderate photoaging. Participants applied a 0.5% ERGO cream to one side of the face and placebo to the other, twice daily for 12 weeks. Skin biopsies were analyzed for collagen density and matrix metalloproteinase-1 (MMP-1) expression.
3) Results
Clinical Scores: The ERGO-treated side showed a 30% reduction in wrinkle depth (p < 0.001) and 25% improvement in skin elasticity (p = 0.002).
Biochemical Analysis: Collagen density increased by 40% (p < 0.001), while MMP-1 expression decreased by 55% (p = 0.001).
4) Mechanistic Insights
ERGO's anti-aging effects are driven by:
ROS Scavenging: ERGO neutralizes UV-induced superoxide radicals, preventing collagen breakdown.
MMP Inhibition: By downregulating MMP-1, ERGO preserves extracellular matrix integrity.
Future Directions
Further Clinical Research:
More large - scale, randomized controlled trials are needed to fully establish the health benefits of ergothioneine tablets in different populations and for various health conditions. This research will help determine the optimal dosage, duration of supplementation, and long - term safety of ergothioneine.
Product Development:
Manufacturers can continue to develop new formulations of ergothioneine tablets, such as combining them with other beneficial nutrients or creating different delivery forms (e.g., chewable tablets, powders) to meet the diverse needs of consumers.
Personalized Nutrition:
With the advancement of personalized nutrition, ergothioneine tablets may be tailored to individual needs based on genetic factors, lifestyle, and health status. For example, individuals with a higher risk of oxidative stress - related diseases may benefit from higher doses of ergothioneine supplementation.
Ergothioneine tablets have a wide range of potential applications in anti - aging, disease prevention, sports performance, and cognitive enhancement. Their unique antioxidant and biological properties make them a promising dietary supplement for improving overall health and well - being. However, to fully realize their potential, further research is needed to establish their safety and efficacy, and regulatory barriers need to be addressed. As the market for natural and preventive health products continues to grow, ergothioneine tablets are likely to play an increasingly important role in the future of health and wellness.
These case studies demonstrate ERGO's broad therapeutic potential across neurodegenerative, metabolic, ocular, and athletic health domains. Its unique mechanism of action-combining antioxidant activity, anti-inflammatory effects, and tissue-specific accumulation-makes it a versatile agent for preventing and managing chronic diseases. While larger clinical trials are needed to confirm efficacy and optimal dosing, ERGO's excellent safety profile and natural origin position it as a promising adjunct to conventional therapies. As research progresses, ERGO may emerge as a cornerstone of preventive and integrative medicine, addressing unmet needs in global health.
Challenge of Extreme Environment in Space and Risk of Oxidative Damage
Bone loss and muscle atrophy
In microgravity environment, the lack of stimulation against gravity leads to accelerated calcium loss, and the monthly bone loss can reach 1%-2%. Long-term exposure may lead to osteoporosis and increase the risk of fracture. At the same time, muscles gradually atrophy due to lack of gravity load, especially the lower limbs and supporting muscles, and it takes months of rehabilitation training to recover after returning to earth.
Cardiovascular system burden
The blood redistributes under microgravity, and the blood volume of the head and upper body increases, resulting in facial swelling and lower limb blood reduction. The heart needs to pump extra blood to maintain circulation, which may lead to cardiovascular function degradation in the long run and increase the risk of arteriosclerosis.
The "silent destroyer" of DNA
High-energy particle penetration protection
Space radiation includes protons released by solar flares, high-energy particles (such as iron cores) in the Milky Way and cosmic rays. These particles can penetrate the shielding of spacecraft and directly damage cell DNA, resulting in single-stranded or double-stranded breakage. The annual radiation dose of astronauts in the International Space Station is 200 times that of the Earth, and the radiation risk of long-term missions (such as Mars exploration) is higher.
Oxidative stress and cell damage
Radiation produces a large number of free radicals (such as hydroxyl radicals) through ionization, which leads to oxidative stress and damages cell membrane, protein and DNA. Studies have shown that the level of blood oxidation markers (such as MDA) in astronauts during space missions increases, mitochondrial function is damaged, and cell aging is accelerated.
Abnormal telomere length and cancer risk
Space environment may lead to changes in chromosome telomere length-telomere lengthening in short-term tasks (which may be related to cell stress response), but telomere shortening after long-term tasks increases genome instability and cancer risk. For example, after the astronauts returned to Earth, chromosome inversion (a sign of radiation exposure) persisted, suggesting that DNA damage was not completely repaired.
Frequently Asked Questions
Is ergothioneine better than NMN?
+
-
Numerous experiments have shown that ergothioneine not only has similar functions to NMN, such as promoting energy metabolism and improving body functions, but also performs better and is safer in terms of anti-aging and anti-oxidation.
Is ergothioneine safe for skin?
+
-
Ergothioneine has been found to play a significant role in the remodelling of the skin barrier function helping to keep skin hydrated and helping to prevent dehydration. Ergothioneine is known to inhibit the collagen destructing enzyme MMP-1.
Does ergothioneine help with aging?
+
-
Background Ergothioneine (ergothioneine) is a naturally occurring antioxidant with emerging evidence supporting its role in cellular protection and anti-aging. However, clinical data on its cosmetic benefits remain limited.
Hot Tags: ergothioneine tablet, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale